» Articles » PMID: 28091333

An Ecological Approach to Reducing Potentially Inappropriate Medication Use: Canadian Deprescribing Network

Overview
Journal Can J Aging
Specialty Geriatrics
Date 2017 Jan 17
PMID 28091333
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Polypharmacy is growing in Canada, along with adverse drug events and drug-related costs. Part of the solution may be deprescribing, the planned and supervised process of dose reduction or stopping of medications that may be causing harm or are no longer providing benefit. Deprescribing can be a complex process, involving the intersection of patients, health care providers, and organizational and policy factors serving as enablers or barriers. This article describes the justification, theoretical foundation, and process for developing a Canadian Deprescribing Network (CaDeN), a network of individuals, organizations, and decision-makers committed to promoting the appropriate use of medications and non-pharmacological approaches to care, especially among older people in Canada. CaDeN will deploy multiple levels of action across multiple stakeholder groups simultaneously in an ecological approach to health system change. CaDeN proposes a unique model that might be applied both in national settings and for different transformational challenges in health care.

Citing Articles

Evaluating the effectiveness of the Smart About Meds (SAM) mobile application among patients discharged from hospital: protocol of a randomised controlled trial.

Tamblyn R, Habib B, Buckeridge D, Weir D, Frolova E, Alattar R BMJ Open. 2024; 14(11):e084492.

PMID: 39581737 PMC: 11590805. DOI: 10.1136/bmjopen-2024-084492.


How to change workflow to enhance implementation of professional services in community pharmacies: A deprescribing case study.

Newport K, Langford A, McEvoy A, Kelly D, Smith T, Tannenbaum C Can Pharm J (Ott). 2024; 157(4):164-170.

PMID: 39092083 PMC: 11290586. DOI: 10.1177/17151635241246975.


Proceedings of the Canadian Medication Appropriateness and Deprescribing Network's 2023 National Meeting.

Pierson T, Arcand V, Farrell B, Gagnon C, Leung L, McCarthy L Drug Saf. 2024; 47(9):829-839.

PMID: 38884849 PMC: 11324714. DOI: 10.1007/s40264-024-01444-2.


Government Direct-to-Consumer Education to Reduce Prescription Opioid Use: A Cluster Randomized Clinical Trial.

Turner J, Halme A, Caetano P, Langford A, Tannenbaum C JAMA Netw Open. 2024; 7(5):e2413698.

PMID: 38809554 PMC: 11137632. DOI: 10.1001/jamanetworkopen.2024.13698.


Strategies to guide the successful implementation of deprescribing in community practice: Lessons learned from the front line.

Turner J, Newport K, McEvoy A, Smith T, Tannenbaum C, Kelly D Can Pharm J (Ott). 2024; 157(3):133-142.

PMID: 38737354 PMC: 11086729. DOI: 10.1177/17151635241240737.